Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19

NCT04638842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2021-10-13

No results posted yet for this study

Summary

This study evaluates the effectiveness of an online Multi-component psychological intervention, that is focused on providing self-support to the Mexican population for the prevention of complicated grief disorder, by reducing grief and strengthening the capacities of the person to handle losses derived from COVID-19 as well as reducing the symptoms of anxiety, depression, hopelessness, and post-traumatic stress, and increasing the quality of sleep and perception of the quality of life.

Conditions

Interventions

BEHAVIORAL

Online Intervention Grief COVID-19

The online Intervention Grief COVID-19 aims to provide to the target population a self-applied intervention based on Cognitive Behavioral Therapy, Mindfulness, Behavioral Activation Therapy, and Positive Psychology, aimed at the Psychoeducation regarding the manifestations of normal grief, advice and guidance on how to find emotional relief, with the aim that survivors allow themselves to validate their experience of emotional pain and recognize it as a normal part of their process of adaptation to loss, what does grief deprived of rights consist of, specifically from the contingency of COVID-19, establish self-care measures for people in different areas of their life (physical, emotional, cognitive and spiritual), direct the survivor to relocate the died in his life without his memory causing suffering, in addition to beginning to resume his life project, adjusting according to his needs and goals. The sessions will be delivered in a frequency of one session every three days.

Sponsors & Collaborators

  • Universidad Nacional Autonoma de Mexico

    collaborator OTHER
  • Universidad Autonoma de Ciudad Juarez

    collaborator OTHER
  • University of Buenos Aires

    collaborator OTHER
  • Universidad Internacional de Valencia

    lead OTHER

Principal Investigators

  • Sofía Cristina Martínez Luna, MD · Universidad Nacional Autonoma de Mexico

  • Paulina Arenas Landgrave, PhD · Universidad Nacional Autonoma de Mexico

  • Anabel de la Rosa, Gómez · Universidad Nacional Autonoma de Mexico

  • Esteban Eugenio Esquivel Santoveña, PhD · Universidad Autónoma de Ciudad Juárez

  • Rosa Olimpia Castellanos Vargas, MD · Universidad Autónoma de Ciudad Juárez

  • Luis Farfallini, PhD · University of Buenos Aires

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-24
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638842 on ClinicalTrials.gov